Craig A. Rosen

Co-Founder at CoGenesys, Inc.

Craig A. Rosen

Craig A. Rosen

Co-Founder at CoGenesys, Inc.

Overview
Career Highlights

PhaseBio Pharmaceuticals, Inc.
CoGenesys, Inc.
Human Genome Sciences, Inc.

RelSci Relationships

1053

Number of Boards

5

Birthday

1958

Age

62

Relationships
RelSci Relationships are individuals Craig A. Rosen likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at CoGenesys, Inc.

Relationship likelihood: Strong

Co-Founder at CoGenesys, Inc.

Relationship likelihood: Strong

Co-Founder at CoGenesys, Inc.

Relationship likelihood: Strong

Founder at Avalon Pharmaceuticals, Inc.

Relationship likelihood: Strong

Partner Emeritus at New Enterprise Associates

Relationship likelihood: Strong

Chief Executive Officer at IVAX LLC

Relationship likelihood: Strong

Chairman-Emeritus at Mid-Atlantic Venture Association

Relationship likelihood: Strong

Senior Analyst at Mehta Partners LLC

Relationship likelihood: Strong

Manager at Dual Therapeutics LLC

Relationship likelihood: Strong

Director & Vice President at Human Genome Sciences, Inc.

Relationship likelihood: Strong

Paths to Craig A. Rosen
Potential Connections via
Relationship Science
You
Craig A. Rosen
Co-Founder at CoGenesys, Inc.
Education
Ph.D. in Microbiology

The University of Rhode Island (commonly referred to as URI) is the principal public research as well as the land grant and sea grant university for the state of Rhode Island. Its main campus is located in the village of Kingston in southern Rhode Island. Additionally, smaller campuses include the Feinstein Campus in Providence, the Narragansett Bay Campus in Narragansett, and the W. Alton Jones Campus in West Greenwich.

Career History
Co-Founder
2005 - Current

TriGenesys, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD.

Senior Vice President & Chief Scientific Officer
Tenure Unconfirmed

Teva is a global generic pharmaceuticals leader and one of the top 15 pharmaceutical companies in the world. Headquartered in Israel, Teva operates in 60 countries and has 46,000 employees worldwide. Established in 1901, Teva takes great pride in its long tradition of leadership and dedication to excellence

Executive Chairman
Prior

PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapies for cardiopulmonary diseases. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.

Boards & Committees
Member, Board of Directors
Prior
Member, Scientific Advisory Board
Prior

The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA

Member, Scientific Advisory Board
Prior

The Institute of Human Virology (IHV) is the first center in the United States - perhaps the world - to combine the disciplines of basic science, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably HIV, the cause of AIDS. Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System, IHV is an institute of the University of Maryland School of Medicine and is home to some of the most globally-recognized and world-renowned experts in the field of human virology. IHV was co-founded by Robert Gallo, MD, director of the of the IHV, William Blattner, MD, retired since 2016 and formerly associate director of the IHV and director of IHV’s Division of Epidemiology and Prevention and Robert Redfield, MD, associate director of the IHV and director of IHV’s Division of Clinical Care and Research. IHV is also comprised of an Animal Models Division, Basic Science Division and Vaccine Research Division. The Institute, with its various laboratory and patient care facilities, is uniquely housed in a 250,000-square-foot building located in the center of Baltimore and our nation’s HIV/AIDS pandemic. IHV creates an environment where multidisciplinary research, education and clinical programs work closely together to expedite the scientific understanding of HIV/AIDS pathogenesis and to develop therapeutic interventions to make AIDS and virally-caused cancers manageable, if not curable, diseases. A particular focus of IHV includes learning how to utilize the body's natural chemistry for its own therapeutic potential and pursuing biologically-based treatment approaches that are less toxic to the body and, often, less costly to the patient and public. IHV also pursues the development of effective therapeutic and preventative vaccines, science's greatest hope in putting an end to the AIDS pandemic. IHV's more than 300 employees include 70 faculty whose research efforts are focused in the area of chronic human viral infection and disease. At present, more than 75 percent of the Institute's clinical and research effort is targeted at HIV infection, but also includes hepatitis C virus, human T cell leukemia viruses 1 and 2, human papillomavirus, herpes viruses and cancer research. IHV’s patient base has grown from just 200 patients to approximately 6,000 in Baltimore and close to 1,000,000 in 6 African and 1 Caribbean nation.

Investments
Details Hidden

TriGenesys, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Craig A. Rosen. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Craig A. Rosen's profile does not indicate a business or promotional relationship of any kind between RelSci and Craig A. Rosen.